Processing a prescription through an electronic ordering system decreases the likelihood of error on that order by 48%, and averts more than 17 million such incidents in US hospitals in 1 year alone.
Processing a prescription through an electronic ordering system decreases the likelihood of error on that order by 48%, and averts more than 17 million such incidents in US hospitals in 1 year alone, according to research published online in the Journal of the American Medical Informatics Association.
“Medication errors in hospitals are common, expensive, and sometimes harmful to patients,” one of the study’s authors Lauren Olsho, PhD, senior associate, Abt Associates, told Formulary.
“This study is the first to derive a rigorous estimate of medication error reduction in hospitals attributable to electronic prescribing through computerized provider order entry [CPOE] systems using existing evidence from the peer-reviewed literature applied to nationally representative data.”
Effect of CPOE on drug errors
Researchers conducted a systematic literature review and applied random-effects meta-analytic techniques to derive a summary estimate of the effect of CPOE on medication errors.
This pooled estimate was combined with data from the 2006 American Society of Health-System Pharmacists Annual Survey, the 2007 American Hospital Association Annual Survey, and the latter’s 2008 Electronic Health Record Adoption Database supplement to estimate the percentage and absolute reduction in medication errors attributable to CPOE.
“Our findings suggest that CPOE can substantially reduce the frequency of medication errors in inpatient acute-care settings even at relatively modest levels of adoption and implementation; however, there is still plenty of room for growth. Current HITECH Act incentives to increase health IT adoption and use will likely prevent millions of additional medication errors each year-over 50 million if all orders were processed via CPOE,” Olsho said. “More evidence is also needed on the extent to which lower error rates result in reduced harm to patients.”
The study was funded by the Agency for Healthcare Research & Quality and carried out by researchers at Abt Associates. n
Coalition promotes important acetaminophen dosing reminders
November 18th 2014It may come as a surprise that each year Americans catch approximately 1 billion colds, and the Centers for Disease Control and Prevention estimates that as many as 20% get the flu. This cold and flu season, 7 in 10 patients will reach for an over-the-counter (OTC) medicine to treat their coughs, stuffy noses, and sniffles. It’s an important time of the year to remind patients to double check their medicine labels so they don’t double up on medicines containing acetaminophen.
Support consumer access to specialty medications through value-based insurance design
June 30th 2014The driving force behind consumer cost-sharing provisions for specialty medications is the acquisition cost and not clinical value. This appears to be true for almost all public and private health plans, says a new report from researchers at the University of Michigan Center for Value-Based Insurance Design (V-BID Center) and the National Pharmaceutical Council (NPC).
Management of antipsychotic medication polypharmacy
June 13th 2013Within our healthcare-driven society, the increase in the identification and diagnosis of mental illnesses has led to a proportional increase in the prescribing of psychotropic medications. The prevalence of mental illnesses and subsequent treatment approaches may employ monotherapy as first-line treatment, but in many cases the use of combination of therapy can occur, leading to polypharmacy.1 Polypharmacy can be defined in several ways but it generally recognized as the use of multiple medications by one patient and the most common definition is the concurrent use of five more medications. The presence of polyharmacy has the potential to contribute to non-compliance, drug-drug interactions, medication errors, adverse events, or poor quality of life.
Medical innovation improves outcomes
June 12th 2013I have been diagnosed with stage 4 cancer of the pancreas, a disease that’s long been considered not just incurable, but almost impossible to treat-a recalcitrant disease that some practitioners feel has given oncology a bad name. I was told my life would be measured in weeks.